MMS

MMS is an innovative, data-focused CRO that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach.

MMS Holdings (MMS) is an innovative, data-focused CRO that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating, and the company has been recognized as a leading CRO in Global Health & Pharma’s international awards programs for three consecutive years.

11/20/2025

The future of CRO partnerships demand a new conversation about value! That’s why MMS Vice President of Commercial Operations, Sandy Robbins, will take the stage to challenge the status quo in CRO compensation models in just 3 weeks at the Clinical Outsourcing Group CRO Summit.

The keynote, “Reimagining CRO Compensation Models for Industry Advancement,” will explore how traditional procurement-driven models often misalign incentives and create inefficiencies. Sandy will unpack:

✔️ How value-based pricing and outcome-linked incentives can reshape collaboration
✔️ The psychological barriers that limit innovation at large CROs
✔️ What sponsors can do to drive better results through smarter compensation strategies

By shifting the conversation from hourly rates to outcomes and impact, Sandy will offer a compelling case for rethinking how clinical research partnerships are structured. Don’t miss this important talk, and review the full agenda here:

https://hubs.li/Q03Vb6yT0

11/19/2025

Join us for a new webinar where MMS experts show how embedding quality control (QC) from the start of the medical writing process can transform your document workflows! Presenters Bhavya Chandregowda, Sharon Oyetunde, Emily Scott, and Katrina O’Connor will discuss:

✅ Building QC-focused writing strategies for process, authoring, communication, and tools
✅ Techniques for achieving first-time quality and reducing rework
✅ Best practices for QC checklists, document storage, and collaboration
✅ How these QC principles apply not just to medical writing, but across all functions in the pharma industry

Clinical development teams are under pressure to produce high quality regulatory documents, accelerate timelines, and reduce costly rework. Register now to see how: https://hubs.li/Q03TWYZ90

11/18/2025

We are proud to share that MMS has been named a Top Workplace in Michigan for the 5th consecutive year! Laura, Michelle, and Samantha represented MMS at the awards ceremony last week and accepted the honor on behalf of every colleague across our organization.

Thank you to each colleague for their passion and expertise to make this recognition possible, and to our clients for trusting us as a partner in advancing life-changing therapies. Together we continue to push boundaries, support strong scientific development, and deliver meaningful outcomes for patients and sponsors alike!

Details here via Detroit Free Press: https://hubs.li/Q03TJKqR0

11/17/2025

MMS is ready to connect with you in Hamburg for the EU Connect 2025!

MMS is bringing insights, connections… and our brand-new game: Rooftop Runner – Conquer Your Clinical Challenges! Set your high score and enter to win Amazon vouchers at the MMS booth.

And, do not miss James Zee, Global Head of Programming at MMS, as he takes the stage in his presentation on "Rethinking Automation in the AI Era" on November 19, 2025 as part of the Machine Learning, AI, and LLM stream (Paper ML13).

For details on the event, visit: https://hubs.li/Q03Tt_K-0

To set a meeting at our booth, stop by or message us at: https://hubs.li/Q03TtX1T0

11/14/2025

In our career transitions series, we hear how transitioning from academia to clinical writing brings unique strengths to modern medical writing teams from Jessica Murdock, PhD! She shares how her research background at MMS supports robust document quality, effective cross functional collaboration, and strategic thinking in medical writing.

One standout insight from Dr. Murdock notes that asking the right questions early, rather than waiting to receive instructions, drives stronger outcomes and demonstrates proactive value to sponsors.

Read her full story to learn what it really takes to succeed in medical writing today: https://hubs.li/Q03TbpGG0

11/13/2025

Are you wondering how long will it really take to recruit an ideal patient population, and what’s the downstream impact on your timeline? With KerusCloud®, you don’t have to guess.

You can simulate multiple recruitment scenarios, understand the bottlenecks, and confidently adjust your approach before your study begins! This German CEO from a leading biotech shares why the outputs from KerusCloud provide a better approach.

Read more: https://hubs.li/Q03SYwRd0

11/12/2025

We’re live at the MMS Cambridge Showcase!
Our team is here at the Babraham Research Campus, connecting with biotech and pharma innovators across Cambridge.
Stop by our table to:
✔️ Learn how MMS supports regulatory strategy, data science, and clinical operations
✔️ Explore KerusCloud simulation technology and strategic statistical consulting
✔️ Share your challenges and discover partnership opportunities
We’re excited to meet you and discuss how MMS can help accelerate your clinical development goals.
📍 Market Restaurant, The Cambridge Building
🕙 Today, 10:00 AM – 3:00 PM

11/12/2025

ICYMI: Our webinar “A Practical Guide to Expedited Regulatory Pathways” is now available on demand! This session pulls back the curtain on how sponsors can strategically align with US and EU accelerated programs to bring therapies closer to patients.

Watch, and you'll discover how to:
✔ Select the pathway best suited to your development stage and data profile
✔ Align your study’s protocol, endpoints, and data strategy with regulatory expectations
✔ Leverage surrogate and intermediate endpoints when appropriate
✔ Understand the emerging impact of the FDA’s priority review voucher initiative

MMS experts dive into pathways like Fast Track, Breakthrough Therapy Designation, Accelerated Approval, Priority Review, and EMA’s PRIME. See it here: https://hubs.li/Q03SyfM60

11/11/2025

Today we honor the bravery of those who have served, and we reaffirm our commitment to supporting their health and wellbeing.

This Veterans Day, the team extends our deepest gratitude to service members and veterans for their courage and sacrifice. We also recognize the struggles that many still face, particularly post‑traumatic stress disorder (PTSD), and appreciate the need for greater understanding and better treatments.

For those interested, this Perspectives article offers insights into emerging therapeutics for veterans with PTSD and how our team at MMS supports research in psychedelic‑assisted therapies to help meet that need: https://hubs.li/Q03Sydzd0

Thank you to our veterans for your service! Your experience drives our purpose and strengthens our commitment to advance meaningful research in drug development and mental health.

11/10/2025

We’re excited to announce the MMS Cambridge Showcase!

On November 11th, our team will be connecting with local biotech and pharma companies across Cambridge.

On November 12th, join us at the Market Restaurant, The Cambridge Building, Babraham Research Campus from 10:00 AM to 3:00 PM for a day of networking, knowledge sharing, and innovation.

What to expect:
✔️Insights into how MMS supports regulatory strategy, data science, and clinical operations
✔️Strategic statistical consulting and KerusCloud simulation technology
✔️Opportunities to share your local challenges and explore partnership possibilities

MMS Holdings is an award-winning, data-focused CRO supporting the pharmaceutical and biotech industries with proven scientific expertise and a global footprint.

Learn more: https://hubs.li/Q03Smf300

11/07/2025

Throughout the year, one thing has remained constant at MMS: our commitment to connection and valuing our colleagues!

From global conferences and team workshops to community events and internal celebrations, we've had the chance to bring colleagues together across locations, functions, and time zones.

These moments that bring us together show our strength, the energy that we bring to our work, and the relationships that power everything we do. Swipe through to see a few of the memories we’ve made in 2025!

11/06/2025

Have you seen how companion diagnostics and biomarkers are transforming the way we fight cancer?

In a recent Perspectives article, we explore how biomarkers, pharmacogenetics, and next-generation sequencing are transforming companion diagnostics, helping sponsors and clinicians:

✔️Match patients to the right therapy

✔️Improve outcomes and reduce side effects

✔️Accelerate progress toward personalized cancer care

Read the full article here: https://hubs.li/Q03S2lCk0

Address

6880 Commerce Boulevard
Canton, MI
48187

Telephone

+17342450310

Website

http://www.mmsholdings.com/

Alerts

Be the first to know and let us send you an email when MMS posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to MMS:

Shortcuts

Want your practice to be the top-listed Clinic in Canton?

Our Story

MMS is an award-winning, data-focused CRO that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating and was named as the Best Global Biotech CRO in the 2018 International Life Sciences Awards.